[1]
M. Stewart, “Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease”, Can IBD Today, vol. 2, no. 2, pp. 19–27, Sep. 2024.